Kim Hyun Il, Jung Da Hyun, Lee Sung Jin, Lee Yong Chan, Lee Sang Kil, Kim Ga Hee, Nam Ho Jae, Lee Sihak, Byon Hyo-Jin, Shin Sung Kwan
Department of Anesthesiology and Pain Medicine, Severance Hospital, Yonsei University College of Medicine, Seoul 03722, Republic of Korea.
Division of Gastroenterology, Department of Internal Medicine, Institute of Gastroenterology, Severance Hospital, Yonsei University College of Medicine, Seoul 03722, Republic of Korea.
J Clin Med. 2024 May 26;13(11):3119. doi: 10.3390/jcm13113119.
Endoscopic submucosal dissection is used to treat early gastric neoplasms. Compared with other endoscopic procedures, it requires higher doses of opioids, leading to adverse events during monitored anesthesia care. We investigated the correlations between clinicopathological characteristics and intraprocedural opioid requirements in patients who underwent endoscopic submucosal dissection under monitored anesthesia care. The medical records of patients who underwent endoscopic submucosal dissection under monitored anesthesia care were retrospectively reviewed. The dependent variable was the total dose of fentanyl administered during the dissection, while independent variables were patient demographics, the American Society of Anesthesiologists physical status classification, preoperative vital sign data, and the pathological characteristics of the neoplasm. Correlations between variables were examined using multiple regression analysis. : The study included 743 patients. The median total fentanyl dose was 100 mcg. Younger age (coefficient -1.37; 95% confidence interval [CI] -1.78 to -0.95), male sex (16.12; 95% CI 6.99-25.24), baseline diastolic blood pressure (0.44; 95% CI 0.04-0.85), neoplasm length (1.63; 95% CI 0.90-2.36), and fibrosis (28.59; 95% CI 17.77-39.42) were positively correlated with the total fentanyl dose. Total fentanyl dose was higher in the differentiated (16.37; 95% CI 6.40-26.35) and undifferentiated cancers group (32.53; 95% CI 16.95-48.11) than in the dysplasia group; no significant differences were observed among the others. The mid-anterior wall (22.69; 95% CI 1.25-44.13), mid-posterior wall (29.65; 95% CI 14.39-44.91), mid-greater curvature (28.77; 95% CI 8.56-48.98), and upper groups (30.06; 95% CI 5.01-55.12) had higher total fentanyl doses than the lower group, whereas doses did not significantly differ for the mid-lesser curvature group. : We identified variables that influenced opioid requirements during monitored anesthesia care for endoscopic submucosal dissection. These may help predict the needed opioid doses and identify factors affecting intraprocedural opioid requirements.
内镜黏膜下剥离术用于治疗早期胃肿瘤。与其他内镜手术相比,它需要更高剂量的阿片类药物,这会导致在麻醉监测护理期间出现不良事件。我们研究了在麻醉监测护理下接受内镜黏膜下剥离术的患者的临床病理特征与术中阿片类药物需求量之间的相关性。回顾性分析了在麻醉监测护理下接受内镜黏膜下剥离术的患者的病历。因变量是剥离过程中芬太尼的总给药剂量,自变量是患者人口统计学特征、美国麻醉医师协会身体状况分级、术前生命体征数据以及肿瘤的病理特征。使用多元回归分析检查变量之间的相关性。该研究纳入了743例患者。芬太尼总剂量中位数为100微克。年龄较小(系数 -1.37;95%置信区间[CI] -1.78至-0.95)、男性(16.12;95%CI 6.99 - 25.24)、基线舒张压(0.44;95%CI 0.04 - 0.85)、肿瘤长度(1.63;95%CI 0.90 - 2.36)和纤维化(28.59;95%CI 17.77 - 39.42)与芬太尼总剂量呈正相关。分化型(16.37;95%CI 6.40 - 26.35)和未分化型癌症组(32.53;95%CI 16.95 - 48.11)的芬太尼总剂量高于发育异常组;其他组之间未观察到显著差异。胃前壁中部(22.69;95%CI 1.25 - 44.13)、胃后壁中部(29.65;95%CI 14.39 - 44.91)、胃大弯中部(28.77;95%CI 8.56 - 48.98)和上部组(30.06;95%CI 5.01 - 55.12)的芬太尼总剂量高于下部组,而胃小弯中部组的剂量无显著差异。我们确定了在麻醉监测护理下内镜黏膜下剥离术中影响阿片类药物需求量的变量。这些变量可能有助于预测所需的阿片类药物剂量,并识别影响术中阿片类药物需求量的因素。